am 251 has been researched along with Hypercapnia in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iring, A | 1 |
| Ruisanchez, É | 1 |
| Leszl-Ishiguro, M | 1 |
| Horváth, B | 1 |
| Benkő, R | 1 |
| Lacza, Z | 1 |
| Járai, Z | 1 |
| Sándor, P | 1 |
| Di Marzo, V | 1 |
| Pacher, P | 1 |
| Benyó, Z | 1 |
1 other study available for am 251 and Hypercapnia
| Article | Year |
|---|---|
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.
Topics: Animals; Arachidonic Acids; Arterial Pressure; Cerebrovascular Circulation; Endocannabinoids; Heart | 2013 |